The pharma major fell more than 5 per cent in a week which triggered the breakdown from a 50-point range where Rs 700 acted as a stiff resistance while levels of Rs 658-660 and above acted as strong support. The stock closed at Rs 652 on 26 August 2022.
Market likely to extend breakouts this week, sector rotation can’t be ruled out
From a technical standpoint, Nifty50 remains firmly on a rising trajectory. If it continues to advance within its defined and laid path, it may go